Serum Institute gets nod to start Covovax trials on children above 7 yrs

Co has already started trials on 12-year-olds and above; trials will start phase wise in children; Poonawalla has said by Jan-Feb trial data may be ready to seek approval

India’s drug regulator on Tuesday allowed Serum Institute of India (SII) to conduct trials of the Novavax Covid-19 vaccine on children aged 7-11.
 
Industry sources confirmed the development. The company had already started trials on 12-17-year-olds.
 
The Subject Expert Committee (SEC), which is advising the Central Drugs Standard Control Organisation (CDSCO), allowed enrolling of candidates aged seven years and above. In July, the expert panel had recommended granting permission to SII for conducting phase 2 and 3 trials of Covovax, the Novavax candidate.
 
The trials are to be conducted for children aged between two and 17 years,